Literature DB >> 2569670

Suppression of experimental autoimmune encephalomyelitis by sulfasalazine.

M Prosiegel, I Neu, G Ruhenstroth-Bauer, G Hoffmann, S Vogl, L Mehlber, A Wildfeuer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2569670     DOI： 10.1056/NEJM198908243210817

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Suppression of experimental autoimmune encephalomyelitis by a new specific leukotriene biosynthesis inhibitor.

Authors:  I S Neu; J Mallinger; A Wildfeuer; L Mehlber
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

2.  Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes.

Authors:  M Pirmohamed; M D Coleman; F Hussain; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

3.  Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.

Authors:  Kirsten S Evonuk; Brandi J Baker; Ryan E Doyle; Carson E Moseley; Christine M Sestero; Bryce P Johnston; Patrizia De Sarno; Andrew Tang; Igor Gembitsky; Sandra J Hewett; Casey T Weaver; Chander Raman; Tara M DeSilva
Journal:  J Immunol       Date:  2015-06-12       Impact factor: 5.422
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.